Norimichi Hattori

Professor
Division of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan

Presentation(s):

• OC 40.2 - Efficacy, Safety, and Pharmacokinetics of Emicizumab Prophylaxis in Patients with Acquired Hemophilia A: Primary Analysis Results from a Phase III Study (AGEHA)

  Monday, July 11, 2022
  3:00 PM – 3:15 PM